TRANSDERMAL DELIVERY OF LIDOCAINE PRILOCAINE MIXTURE FROM CATAPLASM MATRIX

摘要

#$%^&*AU2018101236A420180927.pdf#####ABSTRACT This invention relates to transdermal delivery system for lidocaine and prilocaine eutectic mixture from cataplasm matrix for the management of post herpetic neuralgia (PHN) including other sorts of pain. The formulation includes active ingredient, hydrophilic polymer matrix, humectants, and plasticizer, which provide desirable adhesive characteristics and effective transdermal therapeutic properties for 24 h or multiple days. 1